ANCA-associated vasculitis trials in Israel
2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleRoll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
- Where
- Haifa, Holon, Petah Tikva
- Age
- 6 years and over
- People
- 230 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07444567 - Phase 3Taking peopleA Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
- Where
- Petah Tikva
- Age
- 6 years to 17 years
- People
- 14 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06512883 · EU 2023-508533-14-00